Skip to main content
SpringerLink
Log in

Histamine intolerance: a metabolic disease?

  • Short Communication
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective

To evaluate the evidence regarding the disease concept of histamine intolerance as a state of inadequate histamine inactivation.

Methods

Keyword-based systematic screening of the scientific literature and of public websites focusing on diagnostic and therapeutic procedures.

Results

Histamine intolerance is commonly diagnosed based solely on subjective reporting of symptoms instead of following systematic diagnostic procedures based on objective laboratory and physical parameters. The only effective long-term therapy is avoidance of histamine-containing food.

Conclusions

The concept of histamine intolerance as a metabolic disease is in need of more experimental and clinical evidence and affected patients will benefit from a clear, evidence-based diagnostic and therapeutic regime.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85:1185–96.

    CAS  PubMed  Google Scholar 

  2. Schwelberger HG. Histamine intolerance: overestimated or underestimated? Inflamm Res. 2009;58(Suppl 1):S51–2.

    Article  CAS  Google Scholar 

  3. Amon U, Bangha E, Küster T, Menne A, Vollrath IB, Gibbs BF. Enteral histaminosis: clinical implications. Inflamm Res. 1999;47:291–5.

    Article  Google Scholar 

  4. Sarkadi L. Histamine in food. In: Falus A, editors. Histamine: biology and medical aspects. Budapest: SpringMed Publishing, 2004: 176-85.

  5. Schwelberger HG. Histamine N-methyltransferase (HNMT) enzyme and gene. In: Falus A, editors. Histamine: biology and medical aspects. Budapest: SpringMed Publishing, 2004: 53-9.

  6. Schwelberger HG. Diamine oxidase (DAO) enzyme and gene. In: Falus A, editor. Histamine: biology and medical aspects. Budapest: SpringMed Publishing; 2004. p. 43–52.

    Google Scholar 

  7. Schwelberger HG, Drasche A, Petersen J, Raithel M. Genetic polymorphisms of histamine degrading enzymes: from small-scale screening to high-throughput routine testing. Inflamm Res. 2003;52(Suppl 1):S71–3.

    Article  CAS  PubMed  Google Scholar 

  8. Taylor SL. Histamine food poisoning: toxicology and clinical aspects. Crit Rev Toxicol. 1986;17:91–128.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Biology Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Schöpfstraße 41, 6020, Innsbruck, Austria

    H. G. Schwelberger

Authors
  1. H. G. Schwelberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. G. Schwelberger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwelberger, H.G. Histamine intolerance: a metabolic disease?. Inflamm. Res. 59 (Suppl 2), 219–221 (2010). https://doi.org/10.1007/s00011-009-0134-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-009-0134-3

Keywords

Search

Navigation